Drug Shortage Report for TEVA-OMEPRAZOLE

Last updated on 2025-05-02 History

Report ID	237473
Drug Identification Number	02295415
Brand name	TEVA-OMEPRAZOLE
Common or Proper name	OMEPRAZOLE 20MG TAB
Company Name	TEVA CANADA LIMITED
Market Status	MARKETED
Active Ingredient(s)	OMEPRAZOLE
Strength(s)	20MG
Dosage form(s)	TABLET (DELAYED-RELEASE)
Route of administration	ORAL ORAL
Packaging sizes (GTIN) Click here to see a list of all reports for this drug.	(See additional packaging sizes)
Additional packaging sizes	500
ATC code	A02BC
ATC description	DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage	Disruption of the manufacture of the drug.
Anticipated start date
Actual start date	2024-09-10
Estimated end date	2025-07-20
Actual end date
Shortage status	Actual shortage
Updated date	2025-05-02
Company comments
Health Canada comments
Tier 3 Status	No
Contact Address	30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 32